---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-116676"
form_type: "8-K"
ticker: "CLB"
cik: "0001958086"
company_name: "Core Laboratories Inc. /DE/"
filed_at: "2024-10-23T23:59:59+00:00"
generated_at: "2026-05-30T11:12:31.697119+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Core Lab Q3 revenue $134.4M +7% YoY; EPS ex-items $0.25 +14% YoY; net debt reduced

## Summary
- Revenue $134.4M, up 3% sequentially and over 7% year-over-year.
- Operating income ex-items $18.2M, up 11% sequentially and 14% YoY; margins 14%.
- GAAP EPS $0.25; ex-items $0.25, up 14% sequentially and YoY.
- Free cash flow $10.4M; net debt reduced $11.8M; debt leverage ratio 1.47.
- Declares Q4 dividend $0.01/share, payable Nov 25 to holders of record Nov 4.

## SEC filing metadata
- accession: 0000950170-24-116676
- form_type: 8-K
- ticker: CLB
- cik: 0001958086
- company_name: Core Laboratories Inc. /DE/
- filed_at: 2024-10-23T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1958086/000095017024116676/0000950170-24-116676-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1958086/000095017024116676/clb-20241023.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-116676
- JSON: https://secwatch.observer/filing/0000950170-24-116676.json
- Plain text: https://secwatch.observer/filing/0000950170-24-116676.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.